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Background: Sub-Saharan Africa (SSA) is projected to have a rapid increase in the
number of people living with dementia by 2050. Yet, there is currently no robust
evidence on the risk factors for dementia in the sub-region that could inform context
specific interventions.
Methods: We conducted a systematic review and meta-analysis of observational
studies to determine the dominant and modifiable risk factors for dementia in SSA. We
searched MEDLINE, EMBASE, PsychINFO, and African Journals Online using keywords
for dementia and Alzheimer’s disease as well as the.mp operator for all 47 SSA countries
or regions. We included peer-reviewed original studies with epidemiological designs,
conducted random effect meta-analysis and determined the dominant and modifiable
risk factors for dementia using the inverse of variance method.
Results: A total of 44 studies out of 2,848 met criteria for syntheses. The pooled annual
incidence of dementia from 5,200 cohort risk years was 2.0% [(95% Confidence Interval
(CI) = 1.0–4.0%)]. The pooled prevalence was 5.0% (95% CI = 2.0–7.0%). Older age
was the dominant risk factor for both prevalent [(Standard error (S.E = 0.3, weight =
25.2%)] and incident dementia (S.E = 0.02, weight = 95.8%), while low educational
attainment (S.E = 0.19, weight = 32.6%) and poor predementia cognitive functioning
at baseline (S.E = 0.2, weight = 20.5%) were the best ranked modifiable risk factor for
incident dementia.
Conclusion: Low formal educational attainment which, in SSA, may represent a stable
index of low socioeconomic position and health disadvantage over the life course,
was the most prominent modifiable risk factor for incident dementia. Findings have
implications for deliberate policies targeted at access to education across the life course
as a primary prevention strategy against dementia in SSA.
Keywords: low-and middle-income countries, Sub-Saharan Africa, dementia prevalence, dementia incidence, risk
factors
Ojagbemi et al. Risk Factors for Dementia in Sub-Saharan Africa
INTRODUCTION
Sub-Saharan Africa (SSA) is set to have one of the largest
increases in the population of older people worldwide (1), and
by 2050, approximately 161 million persons who are 60 years
or older will be residents of the sub-region (2). The prevalence
and incidence of dementia increases with age (2, 3). Yet, there is
currently no robust evidence on the risk factors for dementia in
SSA that could inform context specific interventions.
In our previous study (3), we found a 4% pooled prevalence
of clinically diagnosed dementia from an overall sample 6964
community-dwellers who were 60 years or older. The previous
review (3), and others conducted by Alzheimer’s Disease
International (2, 4), had searched databases until May 2016,
and as there were few published information on incidence of
dementia at the time, the evidence was limited to cross-sectional
prevalence of dementia in SSA.
In the succeeding four and half years, the literature on the
epidemiology of dementia in SSA has been boosted by the
publication of new data which have provided valuable additional
information. In particular, longitudinal follow-up data (5–9)
may serve to build on evidence provided by cross-sectional
surveys of dementia in SSA. Such data should allow for an
investigation of the links between cross-sectionally identified risk
predictors (3) and subsequent onset of dementia. Longitudinal
studies may also provide evidence for the relative importance of
each modifiable risk factor for incident dementia, information
required for the prioritization of primary prevention targets
within limited resource contexts of SSA.
The aim of the present study was to conduct a systematic
review andmeta-analyses of epidemiological studies on dementia
in SSA. Specifically, in addition to new information on the
annual incidence of dementia in SSA, we aimed to identify
key modifiable risk factors for onset of dementia among
elders in SSA communities. Estimates of general hospital
frequency, community prevalence, as well as their correlates was
also profiled.
METHODS
This review followed conventional recommendations for the
methodology and reporting of systematic reviews as described
in the guidelines of the National Institute of health and Care
Excellence (NICE) and Preferred Reporting Items for Systematic
reviews and Meta-analyses (PRISMA) (10, 11). We registered
our study protocol in the International prospective register of
systematic reviews (#CRD42021214843).
Search Strategy
An initial search of the African Journals Online (AJOL) database
was conducted on 15th September 2020. This was followed by
a search of the MEDLINE, PsychINFO, and Embase databases.
For these searches, a facet analyses was constructed using
appropriate modifications of the PICO framework (10). The
following keywords identified according to facets in the modified
PICO were searched with the “explode” operator to retrieve
other similar terms: dementia or “Alzheimer’s disease”, AND
BOX 1 | MEDLINE search terms using the Pubmed interphase.
[(dementia OR “Alzheimer’s disease”) AND (epidemiology OR frequency OR
prevalence OR incidence OR factors OR “risk factors” OR “associated
factors’ OR outcome OR mortality)] AND (Angola OR Benin OR Botswana
OR “Burkina Faso” OR Burundi OR Cameroun OR “Central African
Republic” OR Chad OR Congo OR “Cote d’Ivoire” OR Eritrea OR Ethiopia
OR Gabon OR Gambia OR Ghana OR Guinea OR Guinea-Bissau OR
Kenya OR Lesotho OR Liberia OR Madagascar OR Malawi OR Mali OR
Mauritania OR Mauritius OR Mozambique OR Namibia OR Niger OR Nigeria
OR Rwanda OR Senegal OR “Sierra Leone” OR Somalia OR “South Africa”
OR “United Republic of Tanzania” OR Togo OR Uganda OR Zaire OR
Zambia OR ZimbabweOR “Sub Saharan Africa” OR sub-Saharan Africa) AND
((y_5[Filter]) AND (humans[Filter])).
epidemiology OR frequency OR prevalence OR incidence OR
factors OR “risk factors” OR “associated factors” (Box 1).We next
combined a search of each of the 47 SSA countries or regions
by name using the.mp. operator. A second stage consisting
of hand searching of the reference list of relevant articles
retrieved from the databases was also implemented. Limits on
language and publication dates were not imposed in conducting
the searches.
Inclusion Criteria
Studies were included if; (1) they investigated epidemiological
phenomena such as frequencies, prevalence, incidence, risk or
associated factors, (2) they included participants with any type
of dementia regardless of setting, method of ascertainment or
diagnosis, (3) descriptive and analytical cross-sectional studies,
prospective and retrospective cohort studies, case control studies,
randomized controlled trials, non-randomized controlled trials,
as well as quasi-experimental studies.
Exclusion Criteria
We excluded the following types of studies, (1) review papers,
case series, individual case reports, expert opinions, discussion
papers, and position papers; and (2) studies focusing solely on
qualitative data.
Study Assessments and Data Extraction
Study assessment for inclusion and exclusion criteria as well as
subsequent data extraction was conducted by two independent
assessors (AO and APO) based on the descriptions in the original
article. The following information were extracted from each
included study: first author name, publication year, diagnostic
criteria, sample size, average age at baseline, the proportion
of females, hospital frequency, community prevalence, average
follow-up time, cohort risk years, annual incidence, adjusted
relative risks/hazard ratios/odds ratios (RRs/HRs/ORs) with their
95% confidence intervals (Cis), the number of participants
and cases for each exposure level and the main covariates
of Alzheimer’s disease or dementia. Only studies with usable
data and appropriate analytical techniques were combined
in meta-analyses.
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Statistical Methods
Meta-analysis was conducted using estimates reported in the
original articles. The 95% C.I of each estimate was used to
generate standard errors (S.E) using methodologies developed
by the Cochrane collaboration (12). The summary estimates
together with their S.E are presented.
As heterogeneity was expected due to differences in the
type of dementia assessments (clinical diagnostic criteria or
rating scales) as well as setting of studies, a random effect
meta-analysis model was chosen. To reduce the extent of
methodological heterogeneity, we combined studies with similar
diagnostic procedures in the same subgroup meta-analysis. To
determine the extent of statistical heterogeneity, we estimated
the percentage of total variation in estimates reported across
studies that is due to heterogeneity, rather than chance. This was
computed using the I2 test. In the present study, values of I2
> 50% were chosen as evidence of statistical heterogeneity (13).
Publication bias was assessed with the aid of a funnel plot.
For the objective of investigating the most important factors
associated with dementia by rank, we used the log of effect
ratios and the corresponding S.E of the associations. The inverse
of variance method was used for weighting. All analyses were
conducted using the Cochrane reviewmanager (Revman) version
5.3 software (14).
RESULTS
The combined database and hand searches identified a total
of 3127 records. After removing duplicates in the databases
(N = 1,648 articles), 1,479 titles and abstracts were screened.
From these, 51 articles with information relevant to the review
were retrieved and their full text evaluated. After reading
through the texts, 7 articles were further excluded because
they examined broadly defined cognitive impairment and did
not provide information about participants with dementia
(Figure 1). Of the Seven excluded articles, one each was from
Senegal (15), Cameroun (16), South Africa (17), Tanzania (18),
and Rwanda (19), while the remaining two were from Nigeria
(20, 21).
FIGURE 1 | Flow chart showing details of included and excluded studies.
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TABLE 1 | Characteristics of studies of prevalence and incidence of dementia in sub-Saharan Africa.








Hospital or nursing home studies
Ogunniyi et al. (22) Nigeria General hospital medical
In-patients
ICD 9 criteria 37 24.3 67 (9.0) 0.6
Osuntokun et al. (23) Nigeria Autopsy Histological hallmarks 198 46.0 40-85 0
Baiyewu et al. (30) Nigeria Nursing homes DSM III-R criteria 23 47.8 78.7 (8.6) 48
Napon et al. (27) Burkina Faso General hospital In- and
outpatient
DSM IV 15,817 33.3 62.2f 0.5




811 52.2 39f (15–80)g 2.9/4.0
Out/Inpatient




507 <50 72.4 (5.25) 8.87
Amoo et al. (29) Nigeria Neuropsychiatric hospital
In- and out-patient
ICD 10 criteria 240,294 52.8 70.1 (9.8) 0.05
Ramlall et al. (32) South Africa Residential homes for the
elderly
DSM IV-TR 140 69.3 75.2 (8.9) 7.9




7,974 40.2 49–90g 1.9
Callixte et al. (26) Cameroun Neurology Outpatient ICD 10 criteria 912 50.8 68.8 (7.2) 12.4
Paddick et al. (28) Tanzania General hospital medical
In-patients
DSM IV 507 44.4 75a (67–81)g 18.7




Community based cross-sectional surveys
Clinically diagnosed dementia
Osuntokun et al. (33) Nigeria (Idikan) DSM III-R 930 61.2 40–85 0
Hendrie et al. (6)a Nigeria (Idikan) ICD 10/DSM III-R 2,494 71.4 81.0 (9.9) 2.29
Guerchet et al. (34) Benin (Djidja) DSM-IV 502 57.0 76.1 (9.4) 2.6
Yusuf et al. (35) Nigeria (Zaria) ICD 10/DSM IV 322 60.2 75.5 (9.4) 2.8
Guerchet et al. (36)b CAR (Bangui) DSM IV/Alzheimer’s
Association
496 55.6 77.4 (7.3) 8.1
Guerchet et al. (36)b Congo (Brazzaville) DSM IV/Alzheimer’s
Association
520 40.9 74.7 (6.7) 6.7
Paddick et al. (37)c Tanzania (Hai) DSM IV 1,198 56.2 ≥70e 6.4
Ogunniyi et al. (38) Nigeria (Lalupon) DSM IV/Alzheimer’s
Association
613 69.7 72.9 (8.9) 2.9
Guerchet et al. (4)d CAR (Nola) DSM IV 475 N/A N/A 8.4
Guerchet et al. (4)d Congo (Gamboma) DSM IV 529 N/A N/A 5.7
Rating scales defined dementia
Ochayi et al. (39) Nigeria (Jos) CSID 280 89.0 77.2 (9.7) 6.4




2,152 53.8 74.5 (8.4) 10.1
Paraiso et al. (41) Benin CSID/Five word test 1,139 54.1 73.4 (7.2) 3.7
Van der Poel and Heyns
(42)
South Africa (Muangang) CSID, Geriatric mental
state, 10 words list
200 N/A N/A 6
de Jager et al. (43) South Africa
(Eastern Cape)
CSID 1,382 68.6 71.3 (8.3) 11
References Country/location Definition of dementia Years of observation
(Cohort risk)




Community-based longitudinal observation for incident dementia
Hendrie et al. (6) Nigeria (Idikan) CERAD
Neuropsychological
battery/ICD 10 and DSM
III-R criteria
5 (2459) 58.9 77.9 (8.0) 1.4
(Continued)
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TABLE 1 | Continued
References Country/location Definition of dementia Years of observation
(Cohort risk)




Gureje et al. (7) Nigeria (West and
North-central regions)
10-word listing, delayed
recall tests and CHIF
3 (1225) 40.4 74.5 (8.4) 2.2
Samba et al. (8) Rural and Urban Congo DSM IV 2 (847) ≈59.7 73.0 (6.6) 2.38
Ojagbemi et al. (5) West and North-central
Nigeria
10-word listing, Delayed
recall tests and CHIF
5 (1894) 40.2 74.4 (8.8) 2.1
Gao et al. (9) Western Nigeria CERAD
Neuropsychological
battery/ICD 10 and DSM
III-R criteria
N/A (1895) 67 75.7 (5.4) 1.4
Not included in the table are thirteen duplicate publications from six major research programs (Indianapolis Ibadan Dementia Project, Epidemiology of Dementia in Central Africa-EDAC-,
Epidemiology of Dementia in Central Africa-EPIDEMCA-, EPIDEMCA Follow-up, Ibadan Study of Aging, Kilinmajaro cohort from the Hai District of rural Tanzania); SD, Standard deviation;
DSM, Diagnostic and Statistical Manual of Mental disorders; III-R, Text revision of 3rd edition; IV, 4th Edition; IIDP, Indianapolis Ibadan Dementia Project; ICD 10, 10th Revision of the
International Classification of Diseases; EDAC, Epidemiology of Dementia in Central Africa; CAR, Central African Republic; EPIDEMCA, Epidemiology of Dementia in Central Africa; CSID,
Community Screening Instrument for Dementia.
aReported in four studies with 21.6% also meeting 10/66 dementia research group criteria.
bReported in five studies.
cReported in three studies.
dReported in four studies.
eAll participants were 70 years or older.
fMedian.
gRange.
Studies included were published between February 1992 and
December 2019. Over 60% of identified studies were publications
of data from 6 major research programs (Indianapolis Ibadan
Dementia Project, Epidemiology of Dementia in Central
Africa-EDAC-, Epidemiology of Dementia in Central Africa-
EPIDEMCA-, EPIDEMCA Follow-up, Ibadan Study of Aging,
Kilinmajaro cohort from the Hai District of rural Tanzania).
Studies represented all regions in SSA: West, East, Central, and
Southern Africa. However, about 45.2% of identified studies were
from one country, Nigeria.
Types of Study Settings and Designs
Eight studies (22–29) relied on hospital records (Table 1). Also
included in Table 1 are two report of cognitive examination
conducted on older people living in residential or nursing
homes in Nigeria (30) and South Africa (32), respectively. One
study was conducted in a Senegalese primary health center
(PHC) (31) (Table 1). The majority (64.5%) of identified studies
were community based, including reports of eight prospective
longitudinal observations of between 2- and 10-years duration
(5–9, 44–46).
Ascertainment of Dementia
The majority of included studies used a two staged procedure
and made formal clinical diagnoses of dementia according to
codified criteria (47, 48). However, two hospital based (24, 25)
and one PHC study (31) relied on clinicians’ best judgement
of dementia. Also, seven community based cross-sectional
surveys (5, 7, 39–41, 43, 49) used rating scales, including the
community screening instrument for dementia, ten words list
and delayed recall test, five words test and geriatric mental
state examination.
Meta-Analysis
A total of 36 studies provided usable data for quantitative
syntheses (Figure 1).
Prevalence and Incidence of Dementia
Figure 2 presents a forest plot showing the prevalence and
incidence of dementia in SSA. Pooled data from seven studies
including 266, 352 patients generated a frequency of 3.0% (95%
C.I = 1.0–5.0%) for dementia in hospital settings. There was an
indication of statistical heterogeneity in this estimate (I2 = 85%,
p < 0.001). Heterogeneity was investigated and found to be due
to rate outliers of 12.4% (26) and 18.7% (28) reported in two
studies. A community prevalence of 9.0% (95% C.I= 6.0–11.0%)
was estimated from five studies including 5,153 persons who
underwent rating scales assessments for dementia. The pooled
community prevalence of clinically diagnosed dementia from ten
studies including 8,069 participants was 5.0% (95% C.I = 2.0–
7.0%). The pooled annual incidence of dementia from five studies
with a total of 5,200 cohort risk years was 2.0% (1.0–4.0%).
Risk Factors for Dementia
Older age was the most cited and independent factor associated
with prevalent dementia (31, 34, 35, 39–41, 50–53) in SSA
(Figure 3). Older age was also the dominant risk factor
for incident dementia in the sub-region (Table 2). Figure 4
contains the pooled modifiable risk factors for incident
dementia in SSA ranked according to estimates of S.Es of
their independent association with incident dementia. The
strongest evidence on modifiable risk factors is the association
of low educational attainment and poor pre-dementia cognitive
functioning (cognitive reserve) with incident dementia. The
association of vascular and other social risk factors was less
precise by demonstrating large S.Es (Figure 4).
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FIGURE 2 | Forest plot showing hospital frequency, community prevalence and incidence of dementia in sub-Saharan Africa. We centered the display of the
estimates on the point of zero for better illustration.
Publication Bias and Sensitivity Analysis
The funnel plot in Supplementary Figure 1 showed no clear
evidence of publication bias. Sensitivity analyses conducted
according to geographical location of studies suggest that
studies from Nigeria reported distinctly low rates of dementia
compared with studies conducted in other parts of SSA
(Supplementary Figure 2).
DISCUSSION
The pooled annual incidence of dementia in SSA is ≈2%,
while the pooled prevalence is ≈5 and 9%, respectively, when
diagnosed using clinical assessment criteria and rating scales. Age
was the dominant risk factor for both prevalent and incident
dementia, while low educational attainment and poor pre-
dementia cognitive functioning were the prominent modifiable
risk factors for incident dementia in SSA.
Our findings overlap with pooled global estimates (54) of
dementia prevalence, incidence and dominant risk factors as
well as estimates derived from other low- or middle-income
countries (LMICs) (54, 55). Notably, there is still a significant
gap in the literature on the pooled incidence of dementia from
across LMICs to which our findings could be compared (54). Our
current estimate of 5% prevalence of dementia is higher than our
previous rate of 4% (3) because of the inclusion of data from
six additional studies: two from South Africa and one each from
Congo, Central African Republic, Tanzania, and Nigeria. The
Frontiers in Neurology | www.frontiersin.org 6 March 2021 | Volume 12 | Article 627761
Ojagbemi et al. Risk Factors for Dementia in Sub-Saharan Africa
FIGURE 3 | Factors associated with prevalent dementia in Sub-Saharan Africa (ranked by the inverse of variance method).
TABLE 2 | Independent risk factors for incident dementia in Sub-Saharan Africa
(ranked by the inverse of variance method).
Independently associated factors Standard errors Weight %
Age 0.02 95.8




Apolipoprotein E4 homozygosity 0.29 0.5
Rural place of residence 0.35 0.3
Female gender 0.37 0.3
Systemic hypertension 0.38 0.3
Cholesterol 0.38 0.3
Poor social engagement 0.42 0.2
Low density lipoprotein 0.45 0.2
History of smoking 0.45 0.2
Low occupational attainment 0.46 0.2
Low economic status 0.67 0.1
estimated 2% annual incidence of dementia in the present study
is also higher than the 1.3% estimated previously (2, 4). These
increases in rates may suggest greater awareness of dementia in
the sub-region since 2016 or, otherwise, more people may now be
living with dementia in SSA compared to when pooled estimates
of dementia incidence and prevalence were last conducted. An
increase in rates of dementia over time could be expected as it is
in keeping with the phenomenon of global population aging and
the projected increase in the number of older people living with
dementia in SSA and other LMIC contexts (1).
The inclusion of six additional studies estimating prevalence
of dementia in five SSA countries thus meant that our pooled
estimate of prevalence is likely more reflective of the occurrence
of dementia in the sub-region. However, some of the risk factors
identified from cross-sectional studies may be prone to the effect
of reverse causality. This effect may have resulted in larger sizes
of association between dementia and, for example, poor social
engagement or recent change in residence (as would be expected
for placement in long term institutional care). Conversely,
the impact of factors such as depression, undernutrition and
changes in finances, which may be increasingly associated
with dementia overtime may be under-estimated in cross-
sectional investigations. This is because cross-sectional analyses
are inadequate in providing robust evidence for the direction of
association between relevant health conditions overtime.
Our meta-analysis of modifiable risk factors for incident
dementia included five studies. Previous systematic reviews
of incidence of dementia in SSA have relied on two (2) or
four studies (4). We were able to identify one additional
study estimating the incidence of dementia in rural and urban
Congo after a follow-up period of 2 years. Unlike our estimate
of prevalence, the annual incidence of dementia reported in
the present study is unlikely to be generalizable to all SSA
regions. This is partly because 45.2% of the evidence is from
one country, Nigeria. A sensitivity analyses conducted by
geographical location of identified studies showed that studies
from Nigeria reported distinctly low rates of dementia relative to
studies conducted in other parts of SSA. This would suggest that
the relatively large numbers of studies from Nigeria could have
led to an underestimation, rather than overestimation, of the true
rates of dementia in SSA. Even though our funnel plot showed
no clear evidence of publication bias, the observation that many
African studies are published in less visible or less accessible
media could also have affected our pooled estimates.We note that
our search strategy included the African journals online database.
However, our failure to incorporate gray literature in our searches
would mean that a few studies may have been missed, and their
results not included in our meta-analyses.
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FIGURE 4 | Modifiable risk factors for Incident dementia in Sub-Saharan Africa (ranked by the inverse of variance method).
Most of the primary citations identified for the present
systematic review did not report rates of dementia according to
relevant age groups and sex. As such, our reported estimates are
not age or gender standardized. This methodological limitation
could, in part, have accounted for the differences in rates
reported in the present study and those reporting age and
gender standardized rates (2). Variations in pooled rates of
dementia have also been previously reported to reflect the use
of different dementia-ascertainment procedures (56). In the
present systematic review, we have combined data comprising
similar diagnostic procedures in the same meta-analysis model.
Whereas, previous estimates had been based on data pooled from
studies regardless of dementia ascertainment procedures.
Our findings in relations to risk factors for dementia in the
present study were not surprising. Life course higher educational
attainment and pre-dementia cognitive functioning have been
demonstrated as indices of biological (57) and socio-economic
(58) protection against the neuro-degenerative changes that may
result in dementia in older people. This phenomenon is often
viewed as being indicative of cognitive reserve (59). Similar
to reports from higher income countries (56–58), these proxy
indicators of cognitive reserve also appear to have important
association with incident dementia in SSA.
In SSA, low formal educational attainment in particular
may be considered as a stable index of low economic status
over the life course (60). In most of SSA were there is a
steady socio-economic differential in health across the lifespan
(60), the disadvantage of belonging in a low economic status
may accumulate over the life-course (61). This accumulation
may, in turn, translate to significant risks to health, including
the possibility of dementia by the age of 65 years (62). We
note that educational attainment was assessed in the reviewed
studies as either the number of years of formal education
completed or whether participants attended primary, secondary
or higher education. On the other hand, pre-dementia cognitive
functioning was defined by the performance of participants on
the learning phase of the 10-word listing test (10-WDRT). Scores
on this test were dichotomised as “poor,” for dementia free
participants who scored <1 standard deviation (SD) below the
mean score for 3 administrations of the 10-WDRT, and good for
the other dementia free respondents (63).
Research and Clinical Implications
In line with the phenomenon of socio-economic differential in
health, individuals surviving to old age in most of SSA, where
life expectancy at birth is relatively low (64), may include a
comparatively healthier section of the population. This group
may also have a lower latent risk of dementia while those with
higher cumulative morbidity may be more likely to die at a
younger ages (60). In a country like Nigeria, as an example, it is
projected that despite an average life expectancy at birth of about
52 years (65), the population surviving to the age of 65 years may
have the prospect of an additional 15 years of life (66, 67). It is
important to note that Nigeria also provided about 50% of the
studies included in the present review.
Despite biases related sample size which was partly due to
several studies reporting from the same cohort, our meta-analysis
makes several additions to the literature on the epidemiology of
dementia in SSA. First, the addition of six new studies published
in the last 4 years and a half resulted in some increase in
sample size, as well as the possibility of greater precision and
generalization of our findings to most of SSA. Second, we were
able to conduct sub-group analyses demonstrating that pooled
rates of dementia are higher when combining studies using
rating scales ascertainment. Whereas, hospital-based studies as
well as those using clinical diagnostic criteria report lower rates.
The low frequency of dementia found in hospital-based studies
included in the present systematic review may reflect a possible
low healthcare utilization which may also result from prevailing
sociocultural practices and pathways to care (68).
Conclusion
The estimated pooled annual incidence of clinically diagnosed
dementia in SSA is ≈2%, and the prevalence is ≈5%. Estimated
rates vary according to dementia assessment procedures and
types of study populations. As reported globally, older age was
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the dominant risk factor for dementia in the present study,
while low educational attainment was the most prominent
modifiable factor. The present study adds to the literature on the
epidemiology of dementia in SSA by generating potentially more
precise and generalizable estimates due to larger sample size.
The findings have implications for deliberate policies targeted at
access to education across the life course as a primary prevention
strategy against dementia in SSA.
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